We are pleased to share Wellnex Life (ASX: WNX), owner and developer of some of Australia's leading health brands, has recently released a key ASX announcement.
" Financial Year 2024 was a period that had some difficulties in the first half of the financial year 2024 with the delay in the acquisition of Pain Away and the increased costs to complete the acquisition. The completion of the acquisition of Pain Away has transformed the business with increasing revenue, margins and profitability. The main focus in the financial year 2025 apart from continuing to grow the business is to deal with the balance sheet issues which we have a clear plan to deal with this. I want to thank all our shareholders for their continued support as Wellnex Life continues its path of being a major participant in the health and pharmaceutical market."
Congratulations to George Karafotias, Zack Bozinovski, the board and the team at Wellnex Life for reaching this significant milestone.
Read the full Wellnex Life ASX announcement here.
To learn more about Wellnex Life and stay up to date with investor information, subscribe to the Company's Chairman’s List.